Testing’s Critical Role in Stemming the Tide
July 22 2020 - 8:30AM
via NetworkWire — LexaGene Holdings Inc. (TSXV: LXG)
(OTCQB: LXXGF) today announces its placement in an editorial
published by NetworkNewsWire ("NNW"), one of 40+ brands in the
InvestorBrandNetwork (“IBN”), a multifaceted financial news and
publishing company for private and public entities.
To view the full publication,
“Breakthroughs and Advancements in Pathogen Detection Offer
Hope as Virus Cases Surge,” visit: http://nnw.fm/eTKly
Setting a new standard in testing, LexaGene Holdings
Inc. (TSXV: LXG) (OTCQB: LXXGF) (LXG Profile) has
developed a unique pathogen detection instrument—a fully automated
genetic analyzer used to rapidly identify multiple pathogens,
bacteria, and viruses including COVID-19. LexaGene’s breakthrough
technology is highly accurate, designed to be used at sample
collection sites, and can deliver test results on 27 pathogens
and/or antimicrobial resistance factors at once in about an hour.
LexaGene is already working with the FDA on its submission plan for
Emergency Use Authorization (EUA) for COVID-19 testing.
Testing is the first and foremost tool in the
fight against the coronavirus. But with cases in the US and around
the world skyrocketing, the need for faster, more accurate tests is
urgent. Public health experts across the globe agree that early
detection is paramount to controlling the spread of the disease.
Fast, accurate testing allows for contact tracing and isolating
infections to stop rampant spread, but the country is falling short
on testing as demand for tests far outstrips supply and
availability.
About LexaGene Holdings
Inc.
LexaGene is a biotechnology company that develops genetic
analyzers for pathogen detection and other molecular markers for
on-site rapid testing in veterinary diagnostics, food safety and
for use in open-access markets such as clinical research,
agricultural testing and biodefense. End-users simply need to
collect a sample, load it onto the instrument with a sample
preparation cartridge, enter sample ID and press ‘go’. The LX
Analyzer delivers excellent sensitivity, specificity, and breadth
of detection and can return results in about 1 hour. The unique
open-access feature is designed for custom testing so that
end-users can load their own real-time PCR assays onto the
instrument to target any genetic target of interest.
About NetworkNewsWire
NetworkNewsWire (“NNW”) is a financial news and content
distribution company, one of 40+ brands within
our InvestorBrandNetwork (“IBN”),
that provides: (1) access to a network
of wire solutions via NetworkWire to reach all
target markets, industries and demographics in the most effective
manner possible; (2) article and editorial
syndication to 5,000+ news outlets; (3)
enhanced press release solutions to ensure maximum
impact; (4) social media distribution via IBN
to millions of social
media followers; and (5) a full
array of corporate communications solutions. As a multifaceted
organization with an extensive team of contributing journalists and
writers, NNW is uniquely positioned to best serve private and
public companies that desire to reach a wide
audience comprising investors, consumers, journalists and
the general public. By cutting through the overload of information
in today’s market, NNW brings its clients unparalleled visibility,
recognition and brand awareness. NNW is where news, content and
information converge.
For more information, please
visit: https://www.NetworkNewsWire.com
Please see full terms of use and disclaimers on the
NetworkNewsWire website applicable to all content provided by NNW,
wherever published or re-published: http://NNW.fm/Disclaimer
Forward-Looking Statements
This release contains forward-looking statements within the
meaning of Section 27A of the Securities Act of 1933, as amended
and Section 21E of the Securities Exchange Act of 1934, as amended.
All forward-looking statements are inherently uncertain as they are
based on current expectations and assumptions concerning future
events or future performance of the company. Readers are cautioned
not to place undue reliance on these forward-looking statements,
which are only predictions and speak only as of the date hereof. In
evaluating such statements, prospective investors should review
carefully various risks and uncertainties identified in this
release and matters set in the company's SEC filings. These risks
and uncertainties could cause the company's actual results to
differ materially from those indicated in the forward-looking
statements.
Corporate Communications:
NetworkNewsWire (NNW) New York, New York www.NetworkNewsWire.com
212.418.1217 Office Editor@NetworkNewsWire.com
Lexagene (TSXV:LXG)
Historical Stock Chart
From Jun 2024 to Jul 2024
Lexagene (TSXV:LXG)
Historical Stock Chart
From Jul 2023 to Jul 2024